ABL BIOTEC A/S: Financial statements 2012
CVR: 50811018
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -50,503 and a net result of DKK 3,685,841. Equity amounted to DKK 21,513,448. The solvency ratio was 99.8%.
- Gross Profit
- -50,503 kr.
- Profit/Loss
- 3,685,841 kr.
- Equity
- 21,513,448 kr.
- Total Assets
- 21,550,630 kr.
How creditworthy is ABL BIOTEC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of December 31, 2012, MJAKP2 I/S has stepped down as auditor of ABL BIOTEC A/S.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.
